THOUSAND OAKS, Calif., Aug. 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) initiated a voluntary recall on June 26, 2014 for nine packaged lots of Aranesp ® (darbepoetin alfa) (500 mcg) prefilled ...
Amgen is voluntarily recalling 9 lots of an anemia drug from 14 countries outside of the U.S. after syringes were found to have cellulose and polyester particles in ...
This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...
THOUSAND OAKS, Calif., September 7, 2006 -- Amgen (NASDAQ: AMGN) today announced the launch of the Aranesp® (darbepoetin alfa) prefilled SureClick TM autoinjector for patients with ...
LOS ANGELES (MarketWatch) -- Amgen Inc. on Thursday announced it recalled a number of prefilled syringes of its anemia drug Aranesp after particles of what is believed to be cellulose and/or polyester ...
--Amgen initiated a voluntary recall on June 26, 2014 for nine packaged lots of Aranesp ® prefilled syringes from non-U.S. distributors, wholesalers and a number of hospital pharmacies due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback